Abstract

BackgroundPseudomonas chlororaphis strain PA23 is a biocontrol agent capable of suppressing the fungal pathogen Sclerotinia sclerotiorum. This bacterium produces the antibiotics phenazine and pyrrolnitrin together with other metabolites believed to contribute to biocontrol. A mutant no longer capable of inhibiting fungal growth was identified harboring a transposon insertion in a gene encoding a LysR-type transcriptional regulator (LTTR), designated ptrA (Pseudomonas transcriptional regulator). Isobaric tag for relative and absolute quantitation (iTRAQ) based protein analysis was used to reveal changes in protein expression patterns in the ptrA mutant compared to the PA23 wild type.ResultsRelative abundance profiles showed 59 differentially-expressed proteins in the ptrA mutant, which could be classified into 16 clusters of orthologous groups (COGs) based on their predicted functions. The largest COG category was the unknown function group, suggesting that many yet-to-be identified proteins are involved in the loss of fungal activity. In the secondary metabolite biosynthesis, transport and catabolism COG, seven proteins associated with phenazine biosynthesis and chitinase production were downregulated in the mutant. Phenotypic assays confirmed the loss of phenazines and chitinase activity. Upregulated proteins included a lipoprotein involved in iron transport, a flagellin and hook-associated protein and four proteins categorized into the translation, ribosome structure and biogenesis COG. Phenotypic analysis revealed that the mutant exhibited increased siderophore production and flagellar motility and an altered growth profile, supporting the proteomic findings.ConclusionPtrA is a novel LTTR that is essential for PA23 fungal antagonism. Differential protein expression was observed across 16 COG categories suggesting PtrA is functioning as a global transcriptional regulator. Changes in protein expression were confirmed by phenotypic assays that showed reduced phenazine and chitinase expression, elevated flagellar motility and siderophore production, as well as early entrance into log phase growth.

Highlights

  • Pseudomonas chlororaphis strain PA23 is a biocontrol agent capable of suppressing the fungal pathogen Sclerotinia sclerotiorum

  • This bacterium produces a number of compounds including phenazine 1-carboxylic acid (PCA), 2-hydroxyphenazine (2OH-PHZ), pyrrolnitrin, protease, lipase, chitinase and siderophores, some of which have been shown to contribute to fungal antagonism [3,4,5]

  • Given the remarkably complex regulatory network that oversees the production of antifungal compounds, the aim of the current study was to understand the global impact of the ptrA mutation on PA23 protein expression

Read more

Summary

Introduction

Pseudomonas chlororaphis strain PA23 is a biocontrol agent capable of suppressing the fungal pathogen Sclerotinia sclerotiorum. Pseudomonas chlororaphis strain PA23 is a biocontrol agent able to protect canola from stem rot disease caused by the fungus Sclerotinia sclerotiorum (Lib.) de Bary [1,2] This bacterium produces a number of compounds including phenazine 1-carboxylic acid (PCA), 2-hydroxyphenazine (2OH-PHZ), pyrrolnitrin, protease, lipase, chitinase and siderophores, some of which have been shown to contribute to fungal antagonism [3,4,5]. Poor field performance is likely due, at least in part, to variable expression of genes and gene products required for disease suppression It is essential, to elucidate the molecular mechanisms mediating PA23 biocontrol so that production of the pathogen-suppressing factor (s) can be optimized in the environment

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.